Načítá se...

Lack of antibody-mediated cross-protection between SARS-CoV-2 and SARS-CoV infections

BACKGROUND: The novel coronavirus (SARS-CoV-2) shares approximately 80% whole genome sequence identity and 66% spike (S) protein identity with that of SARS-CoV. The cross-neutralization between these viruses is currently not well-defined. METHODS: Here, by using the live SARS-CoV-2 virus infection a...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:EBioMedicine
Hlavní autoři: Yang, Ren, Lan, Jiaming, Huang, Baoying, A, Ruhan, Lu, Mingqing, Wang, Wen, Wang, Wenling, Li, Wenhui, Deng, Yao, Wong, Gary, Tan, Wenjie
Médium: Artigo
Jazyk:Inglês
Vydáno: Elsevier 2020
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7372296/
https://ncbi.nlm.nih.gov/pubmed/32707445
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ebiom.2020.102890
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!